Experience of using alloplant biomaterial in the treatment of congenital aortic pathology

Abstract

The article is devoted to the analysis of the first clinical application of alloplant biomaterial in cardiac surgery for the treatment of congenital heart defects. Alloplant technology— processing of cadaver material— was developed by Professor E.R.Muldashev in the late 1970s for the needs of ophthalmic surgery and has proven itself to be the best. Taking into account the extensive positive experience in ophthalmic surgery, we jointly created an alloplant from the pulmonary artery, aorta, and then from the vena cava for use in the surgical treatment of congenital heart defects, including in children of the first year of life. The article presents the results of treatment of a small group of patients with similar diagnoses and a long follow-up period.